Trial Profile
A Prospective, Single-centre study to evaluate the efficacy and safety of Defibrotide for the prevention of Hepatic Veno-Occlusive Disease in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs Defibrotide (Primary)
- Indications Hepatic veno-occlusive disease
- Focus Adverse reactions; Therapeutic Use
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association
- 19 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association